Frontier Group Holdings ULCC 深 沪
等待开盘 08-02 09:30:00 美东时间
3.97
-0.410
-9.36%
华盛通- 最 高4.205
- 今 开4.18
- 成交量 430.42万股
- 最 低 3.95
- 昨 收 4.38
- 总市值 9.05亿
- 52周最高 10.26
- 市盈率 静 10.70
- 换手率 0.00%
- 52周最低 2.79
- 委 比 5.27%
- 总股本 2.28亿
- 历史最高 22.70
- 量 比 1.27
- 振 幅 5.82%
- 历史最低 2.79
- 每 手 1
- 风险率 1.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Outlook For Allegiant Travel
Allegiant Travel (NASDAQ:ALGT) will release its quarterly earnings report on Mo...
今天 04:05
JetBlue Airways's Earnings: A Preview
JetBlue Airways (NASDAQ:JBLU) is set to give its latest quarterly earnings repo...
07-29 04:01
Alaska Air Gr's Earnings Outlook
Alaska Air Gr (NYSE:ALK) is preparing to release its quarterly earnings on Wedn...
07-23 02:02
深夜，航空股全线暴涨！
来源：民航之翼 当特朗普的关税大棒还在几起几落，中东地区战争阴云未散，全球经济不确定因素持续增加，所有人都以为全球民航业前景黯淡之际。 没想到，2...
07-12 19:31
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
UBS analysts listed top and bottom-ranked stocks based on a key set of drivers for equities, they named REVS. UBS’s REVS framework consists of elements that are key drivers for equity performance, inc...
07-11 23:33
Frontier Group Holdings (ULCC) Receives a Buy from Barclays
Barclays analyst Brandon Oglenski maintained a Buy rating on Frontier Group Hol...
07-10 15:48
Reuters Reports U.S. Senate Votes To Confirm Trump Nominee Bryan Bedford To Head Federal Aviation Administration
The U.S. Senate Wednesday voted 53 to 43 approve Republic Airways CEO Bryan Bedford to head the Federal Aviation Administration.
07-10 02:41
美股大行评级 | 潜在涨幅336.36%！Canaccord Genuity上调ATAI Life Sciences目标价至12美元，维持"买入"评级
Redburn Atlantic：下调Adobe(ADBE)评级至"卖出"，目标价从420美元降至280美元
07-03 11:01
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
